🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
The purpose of this study is to determine the correct dose and safety of ad...
Status
Active Not Recruiting
Location
Washington University School of Medicine, Siteman Cancer Center
Start Date
2017-06-26
Trial ID
NCT03064867
Treatments Being Tested
This is a multi-center, phase I/II trial to evaluate the safety and efficac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-06-30
Trial ID
NCT06009107
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Ibrutin...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04994626
Treatments Being Tested
This clinical trial is a Phase II study investigating the effectiveness and...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-01-15
Trial ID
NCT07372352
Treatments Being Tested
This study is undertaken to generate clinical data on GSK Biologicals' comb...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-03
Trial ID
NCT00892775
This phase II/III trial compares the side effects and activity of oral azac...
Status
Active Not Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2021-05-20
Trial ID
NCT04799275
By doing this study, it is the hope to learn whether an injection of the me...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT07539155
Treatments Being Tested
Participants will receive vaccination for measles, mumps, and rubella (MMR)...
Status
Completed
Location
Zambia Emory HIV Research Project
Start Date
2015-08
Trial ID
NCT02589678
Treatments Being Tested